Volker Knappertz
CIK 1754122 · EVP, Research and Development · last filed 2024-02-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.86M
Companies
2
Total Filings
22
Lifetime Open-Market Net
-$1.26M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | EVP, Research and Development | 319,128 | $15.24 | $4.86M | -$167.9K | 4 | 2024-02-29 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Chief Medical Officer | 92,412 | $218.96 | $20.23M | -$1.09M | 17 | 2021-03-30 |
Recent Filings · Page 3 of 3
22 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-05 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | −3,732 | -$54.0K | EDGAR |
| 2019-02-28 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +4,296 | -$51.6K | EDGAR |
Showing 21–22 of 22
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.